{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:31:29Z","timestamp":1767652289990,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"N\u00eemes University Hospital"},{"DOI":"10.13039\/501100008222","name":"Universit\u00e9 de Montpellier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In France, more than 10 million women at \u201daverage\u201d risk of breast cancer (BC), are included in the organized BC screening. Existing predictive models of BC risk are not adapted to the French population. Thus, we set up a new score in the French H\u00e9rault region and looked for subgroups at a graded level of risk in women at \u201daverage\u201d risk. We recruited a retrospective cohort of women, aged 50 to 60, who underwent the organized BC screening, and included 2241 non-cancer women and 527 who developed a BC during a 12-year follow-up period (2006-2018). The risk factors identified were high breast density (ACR BI-RADS grading)(B vs A: HR\u00a0=\u00a01.41, 95%CI [1.05; 1.9], p\u00a0=\u00a00.023; C vs A: HR\u00a0=\u00a01.65 [1.2; 2.27], p\u00a0=\u00a00.02 ; D vs A: HR\u00a0=\u00a02.11 [1.25;3.58], p\u00a0=\u00a00.006), a history of maternal breast cancer (HR\u00a0=\u00a01.61 [1.24; 2.09], p &lt; 0.001), and socioeconomic difficulties (HR 1.23 [1.09; 1.55], p\u00a0=\u00a00.003). While early menopause (HR\u00a0=\u00a00.36 [0.13; 0.99], p\u00a0=\u00a00.003) and an age at menarche after 12 years (HR\u00a0=\u00a00.77 [0.63; 0.95], p\u00a0=\u00a00.047) were protective factors. We identified 3 groups at risk: lower, average, and higher, respectively. A low threshold was characterized at 1.9% of 12-year risk and a high threshold at 4.5% 12-year risk. Mean 12-year risks in the 3 groups of risk were 1.37%, 2.68%, and 5.84%, respectively. Thus, 12% of women presented a level of risk different from the average risk group, corresponding to 600,000 women involved in the French organized BC screening, enabling to propose a new strategy to personalize the national BC screening. On one hand, for women at lower risk, we proposed to reduce the frequency of mammograms and on the other hand, for women at higher risk, we suggested intensifying surveillance.<\/jats:p>","DOI":"10.1038\/s41598-021-98604-6","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T10:20:00Z","timestamp":1632738000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Determination of thresholds of risk in women at average risk of breast cancer to personalize the organized screening program"],"prefix":"10.1038","volume":"11","author":[{"given":"Emmanuel","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Daures","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Landais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"98604_CR1","unstructured":"Sant\u00e9 publique france. Sante publique france - Cancers. Tech. Rep. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/cancers. (2021)."},{"key":"98604_CR2","doi-asserted-by":"crossref","unstructured":"Lefeuvre, D., Catajar, N., Le, C., Benjamin, B. & Bousquet, P.\u00a0J. D\u00e9pistage du cancer du sein : impact sur les trajectoires de soins. Tech. Rep., Institut national du cancer (2018). https:\/\/www.e-cancer.fr\/content\/download\/238001\/3268333\/file\/Depistage_du_cancer_du_sein_impact_sur_les_trajctoires_de_soins_mel_20180608.pdf.","DOI":"10.1016\/j.respe.2018.01.050"},{"key":"98604_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-13-130","author":"N Jay","year":"2013","unstructured":"Jay, N., Nuemi, G., Gadreau, M. & Quantin, C. A data mining approach for grouping and analyzing trajectories of care using claim data: The example of breast cancer. BMC Med. Informatics Decis. Mak.https:\/\/doi.org\/10.1186\/1472-6947-13-130 (2013).","journal-title":"BMC Med. Informatics Decis. Mak."},{"key":"98604_CR4","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. D\u00e9pistage du cancer du sein en France : identification des femmes \u00e0 haut risque et modalit\u00e9s de d\u00e9pistage. Tech. Rep., HAS (2014). www.has-sante.fr."},{"key":"98604_CR5","unstructured":"Sant\u00e9 publique France. Taux de participation au programme de d\u00e9pistage organis\u00e9 du cancer du sein 2018-2019 et \u00e9volution depuis 2005. Tech. Rep., Sant\u00e9 publique France (2020). https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/cancers\/cancer-du-sein\/articles\/taux-de-participation-au-programme-de-depistage-organise-du-cancer-du-sein-2018-2019-et-evolution-depuis-2005."},{"key":"98604_CR6","unstructured":"INCa. Plan d\u2019action pour la r\u00e9novation du d\u00e9pistage organis\u00e9 du cancer du sein. Tech. Rep., Institut National du Cancer (2017). https:\/\/solidarites-sante.gouv.fr\/IMG\/pdf\/plan-actions-renov-cancer-sein-2.pdf."},{"key":"98604_CR7","unstructured":"Cases, C. et\u00a0al. Rapport du comit\u00e9 d\u2019orientation sur le d\u00e9pistage du cancer du sein. Tech. Rep., INCA (2016). http:\/\/www.concertation-depistage.fr\/wp-content\/uploads\/2016\/10\/depistage-cancer-sein-rapport-concertation-sept-2016.pdf."},{"key":"98604_CR8","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail, M. H. et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl. Cancer Inst. 81, 1879\u20131886. https:\/\/doi.org\/10.1093\/jnci\/81.24.1879 (1989).","journal-title":"J. Natl. Cancer Inst."},{"key":"98604_CR9","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/jnci\/94.11.844","volume":"94","author":"DM Euhus","year":"2002","unstructured":"Euhus, D. M. et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J. Natl. Cancer Inst. 94, 844\u2013851 (2002).","journal-title":"J. Natl. Cancer Inst."},{"key":"98604_CR10","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","volume":"91","author":"AC Antoniou","year":"2004","unstructured":"Antoniou, A. C., Pharoah, P. P., Smith, P. & Easton, D. F. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br. J. Cancer 91, 1580\u20131590. https:\/\/doi.org\/10.1038\/sj.bjc.6602175 (2004).","journal-title":"Br. J. Cancer"},{"key":"98604_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/sim.1668","volume":"23","author":"J Tyrer","year":"2004","unstructured":"Tyrer, J., Duffy, S. W. & Cuzick, J. A breast cancer prediction model incorporating familial and personal risk factors. Stat. Med. 23, 1111\u20131130. https:\/\/doi.org\/10.1002\/sim.1668 (2004).","journal-title":"Stat. Med."},{"key":"98604_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/pgfar04110","volume":"4","author":"DG Evans","year":"2016","unstructured":"Evans, D. G. et al. Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Programme Grants Appl. Res. 4, 1\u2013210. https:\/\/doi.org\/10.3310\/pgfar04110 (2016).","journal-title":"Programme Grants Appl. Res."},{"key":"98604_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10549-013-2428-y","volume":"138","author":"R Pastor-Barriuso","year":"2013","unstructured":"Pastor-Barriuso, R. et al. Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: A population-based cohort study. Breast Cancer Res. Treat. 138, 249\u2013259. https:\/\/doi.org\/10.1007\/s10549-013-2428-y (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"98604_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0895-4356(97)00013-9","volume":"50","author":"A McTiernan","year":"1997","unstructured":"McTiernan, A., Gilligan, M. A. & Redmond, C. Assessing individual risk for breast cancer: Risky business. J. Clin. Epidemiol. 50, 547\u2013556. https:\/\/doi.org\/10.1016\/S0895-4356(97)00013-9 (1997).","journal-title":"J. Clin. Epidemiol."},{"key":"98604_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-018-0947-5","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Assessment of performance of the Gail model for predicting breast cancer risk: A systematic review and meta-analysis with trial sequential analysis. Breast Cancer Res.https:\/\/doi.org\/10.1186\/s13058-018-0947-5 (2018).","journal-title":"Breast Cancer Res."},{"key":"98604_CR16","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing (2019)."},{"key":"98604_CR17","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","volume":"377","author":"LS M\u00f8rch","year":"2017","unstructured":"M\u00f8rch, L. S. et al. Contemporary hormonal contraception and the risk of breast cancer. New Engl. J. Med. 377, 2228\u20132239. https:\/\/doi.org\/10.1056\/NEJMoa1700732 (2017).","journal-title":"New Engl. J. Med."},{"key":"98604_CR18","unstructured":"D\u2019Orsi, C.\u00a0J. & Acr. 2013 ACR BI-RADS Atlas: Breast Imaging Reporting and Data System (American College of Radiology, 2014)."},{"key":"98604_CR19","unstructured":"WHO. Global recommendations on physical activity for health (WHO Library Cataloguing-in-Publication Data, 2010)."},{"key":"98604_CR20","unstructured":"Sant\u00e9 publique France (MILDECA). Nouvelles recommandations sur l\u2019alimentation, y compris l\u2019alcool, l\u2019activit\u00e9 physique et la s\u00e9dentarit\u00e9 | Mildeca. Tech. Rep. (2019). https:\/\/www.drogues.gouv.fr\/actualites\/."},{"key":"98604_CR21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/ped.12296","volume":"56","author":"L Lalys","year":"2014","unstructured":"Lalys, L. & Pineau, J. C. Age at menarche in a group of French schoolgirls. Pediatr. Int. 56, 601\u2013604. https:\/\/doi.org\/10.1111\/ped.12296 (2014).","journal-title":"Pediatr. Int."},{"key":"98604_CR22","first-page":"2015","volume":"1642","author":"S Volant","year":"2017","unstructured":"Volant, S. Un premier enfant \u00e0 28,5 ans en 2015: 4,5 ans plus tard qu\u2019en 1974. INSEE Premi\u00e8re 1642, 2015\u20132018 (2017).","journal-title":"INSEE Premi\u00e8re"},{"key":"98604_CR23","unstructured":"Robert-Bob\u00e9e, I. 2,1 enfants par femme pour les g\u00e9n\u00e9rations n\u00e9es entre 1947 et 1963. Insee Focus. Avril (2015)."},{"key":"98604_CR24","unstructured":"WHO. Planning Guide for national implementation of the Global Strategy for Infant and Young Child Feeding. Tech. Rep., WHO (2007). http:\/\/www.who.int\/maternal_child_adolescent\/documents\/9789241595193\/en\/."},{"key":"98604_CR25","unstructured":"Coll\u00e8ge National des Gyn\u00e9cologues et Obst\u00e9triciens Fran\u00e7ais. La m\u00e9nopause. Tech. Rep. http:\/\/www.cngof.fr\/communiques-de-presse\/108-menopause."},{"key":"98604_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/eurpub\/cku231","volume":"25","author":"E Labbe","year":"2015","unstructured":"Labbe, E. et al. A new reliable index to measure individual deprivation: The EPICES score. Eur. J. Public Heal. 25, 604\u2013609. https:\/\/doi.org\/10.1093\/eurpub\/cku231 (2015).","journal-title":"Eur. J. Public Heal."},{"key":"98604_CR27","first-page":"216","volume":"34","author":"EN Breslow","year":"1972","unstructured":"Breslow, E. N. Contribution to discussion of paper by D. R. Cox. J. R. Stat. Soc. Ser. B 34, 216\u2013217 (1972).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"98604_CR28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","volume":"13","author":"N Hamajima","year":"2012","unstructured":"Hamajima, N. et al. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol. 13, 1141\u20131151. https:\/\/doi.org\/10.1016\/S1470-2045(12)70425-4 (2012).","journal-title":"Lancet Oncol."},{"key":"98604_CR29","unstructured":"NICE. Summary of recommendations on surveillance for women with no personal history of breast cancer moderate risk high risk age moderate risk of breast cancer. Tech. Rep. https:\/\/www.nice.org.uk\/guidance\/cg164\/resources\/educational-resource-fbc-surveillance-table-pdf-190125757."},{"key":"98604_CR30","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0083","author":"L Jacobs","year":"2018","unstructured":"Jacobs, L. et al. Breast cancer screening and diagnosis, version 3.2018. JNCCN J. Natl. Compr. Cancer Netw.https:\/\/doi.org\/10.6004\/jnccn.2018.0083 (2018).","journal-title":"JNCCN J. Natl. Compr. Cancer Netw."},{"key":"98604_CR31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","volume":"164","author":"AL Siu","year":"2016","unstructured":"Siu, A. L. Screening for breast cancer: U.s. preventive services task force recommendation statement. Ann. Intern. Med. 164, 279\u2013296. https:\/\/doi.org\/10.7326\/M15-2886 (2016).","journal-title":"Ann. Intern. Med."},{"key":"98604_CR32","unstructured":"NICE. Overview | familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | guidance | nice. Tech. Rep. https:\/\/www.nice.org.uk\/guidance\/cg164."},{"key":"98604_CR33","unstructured":"NCCN. Genetic\/familial high-risk assessment: Breast, ovarian, and pancreatic. Tech. Rep. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=2&id=1503."},{"key":"98604_CR34","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1158\/1940-6207.CAPR-11-0458","volume":"5","author":"DGR Evans","year":"2012","unstructured":"Evans, D. G. R. et al. Assessing individual breast cancer risk within the u.k. national health service breast screening program: A new paradigm for cancer prevention. Cancer Prev. Res. 5, 943\u2013951. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-11-0458 (2012).","journal-title":"Cancer Prev. Res."},{"key":"98604_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw357","author":"M Gabrielson","year":"2017","unstructured":"Gabrielson, M. et al. Cohort profile: The karolinska mammography project for risk prediction of breast cancer (karma). Int. J. Epidemiol.https:\/\/doi.org\/10.1093\/ije\/dyw357 (2017).","journal-title":"Int. J. Epidemiol."},{"key":"98604_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41523-017-0035-5","volume":"3","author":"LJ Esserman","year":"2017","unstructured":"Esserman, L. J. The wisdom study: Breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer 3, 34. https:\/\/doi.org\/10.1038\/s41523-017-0035-5 (2017).","journal-title":"NPJ Breast Cancer"},{"key":"98604_CR37","unstructured":"Delaloge, S. MyPeBS Protocol n: UC-0109\/1805. Tech. Rep. (2018). http:\/\/www.adecam.fr\/mypebs\/protocole_etude.pdf."},{"key":"98604_CR38","unstructured":"UNICANCER. My personalized breast screening clinicaltrials.gov. Tech. Rep. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03672331."},{"key":"98604_CR39","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.1002","author":"S Sorscher","year":"2021","unstructured":"Sorscher, S. Universal genetic testing to identify pathogenic germline variants in patients with cancer. JAMA Oncol.https:\/\/doi.org\/10.1001\/jamaoncol.2021.1002 (2021).","journal-title":"JAMA Oncol."},{"key":"98604_CR40","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch, F. J. et al. Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 3, 1190\u20131196. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0424 (2017).","journal-title":"JAMA Oncol."},{"key":"98604_CR41","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1001\/jamaoncol.2017.0342","volume":"3","author":"EI Obeid","year":"2017","unstructured":"Obeid, E. I., Hall, M. J. & Daly, M. B. Multigene panel testing and breast cancer risk: Is it time to scale down?. JAMA Oncol. 3, 1176\u20131177. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0342 (2017).","journal-title":"JAMA Oncol."},{"key":"98604_CR42","unstructured":"INCa. Avis de la conf\u00e9rence des citoyennes. Tech. Rep., INCa (2016). https:\/\/www.e-cancer.fr\/content\/download\/159248\/2030496\/file\/Depistagecancersein-aviscitoyennes-mars2016.pdf."},{"key":"98604_CR43","unstructured":"INCa. Avis de la conf\u00e9rence des professionnels. Tech. Rep., INCa (2016). https:\/\/www.e-cancer.fr\/content\/download\/159250\/2030514\/file\/Depistagecancersein-avisprofessionnels-mars2016.pdf."},{"key":"98604_CR44","first-page":"1839","volume":"1137","author":"I Doutriaux-Dumoulin","year":"2007","unstructured":"Doutriaux-Dumoulin, I., Allioux, A., Campion, L., Meingan, P. & Molina, L. Cancers d\u00e9tect\u00e9s par le deuxi\u00e8me lecteur\u202f: analyse des donn\u00e9es de la campagne de d\u00e9pistage du cancer du sein en Loire-Atlantique, 2003\u20132005 (nouveau cahier des charges). J. Radiol. 1137, 1839\u20131910 (2007).","journal-title":"J. Radiol."},{"key":"98604_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1148\/radiology.191.1.8134580","volume":"191","author":"EL Thurfjell","year":"1994","unstructured":"Thurfjell, E. L., Lernevall, K. A. & Taube, A. A. Benefit of independent double reading in a population-based mammography screening program. Radiology 191, 241\u2013244. https:\/\/doi.org\/10.1148\/radiology.191.1.8134580 (1994).","journal-title":"Radiology"},{"key":"98604_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.7326\/0003-4819-138-3-200302040-00008","volume":"138","author":"PA Carney","year":"2003","unstructured":"Carney, P. A. et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann. Intern. Med. 138, 168\u2013175. https:\/\/doi.org\/10.7326\/0003-4819-138-3-200302040-00008 (2003).","journal-title":"Ann. Intern. Med."},{"key":"98604_CR47","doi-asserted-by":"publisher","unstructured":"Drukteinis, J. S., Mooney, B. P., Flowers, C. I. & Gatenby, R. A. Beyond mammography: New frontiers in breast cancer screening. https:\/\/doi.org\/10.1016\/j.amjmed.2012.11.025 (2013).","DOI":"10.1016\/j.amjmed.2012.11.025"},{"key":"98604_CR48","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1001\/jama.2020.0572","volume":"323","author":"CE Comstock","year":"2020","unstructured":"Comstock, C. E. et al. Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening. JAMA - J. Am. Med. Assoc. 323, 746\u2013756. https:\/\/doi.org\/10.1001\/jama.2020.0572 (2020).","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"98604_CR49","unstructured":"Wilson, J. M. G. & Jungner, G. & World Health Organization. Principles and practice of screening for disease. Public Health Papers 34 (1968)."},{"key":"98604_CR50","first-page":"23","volume":"32","author":"G Iatrakis","year":"2018","unstructured":"Iatrakis, G. et al. Manosmed University\u2019s Risk factor calculator for female breast cancer: Preliminary data. Rev. Clin. Pharmacol. Pharmacokinet. Int. Ed. 32, 23\u201327 (2018).","journal-title":"Rev. Clin. Pharmacol. Pharmacokinet. Int. Ed."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98604-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98604-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98604-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:09:39Z","timestamp":1670083779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98604-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98604"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98604-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19104"}}